SBI Securities’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22 Sell
5
-7
-58% -$31 ﹤0.01% 3829
2026
Q1
$46 Buy
12
+7
+140% +$29 ﹤0.01% 3593
2025
Q4
$19 Sell
5
-139
-97% -$1.19K ﹤0.01% 3786
2025
Q3
$2.03K Sell
144
-98
-40% -$1.53K ﹤0.01% 2417
2025
Q2
$4.65K Hold
242
﹤0.01% 2015
2025
Q1
$2.68K Buy
242
+178
+278% +$2.12K ﹤0.01% 2169
2024
Q4
$1.06K Buy
+64
New +$799 ﹤0.01% 2576

Other funds holding OM

SBI Securities's OM Position: Q2 2026 in Review

SBI Securities reduced its Outset Medical (OM) stake by 58% in Q2 2026, selling an estimated $31 and leaving 5 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #3829.

SBI Securities first reported a position in OM in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.65K in Q2 2025. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • SBI Securities held 5 shares of Outset Medical worth $22 as of Q2 2026.
  • SBI Securities sold 7 Outset Medical shares in Q2 2026, an estimated $31.
  • Outset Medical made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3829 holding.
  • SBI Securities first reported a position in Outset Medical in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Outset Medical position peaked at $4.65K in Q2 2025.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.